Compare $AQB vs $PMCB | Chartloom

Compare

$AQB vs $PMCB

AquaBounty Technologies Inc · PharmaCyte Biotech Inc

AQB

AquaBounty Technologies Inc

PMCB

PharmaCyte Biotech Inc

Compare $AQB vs $PMCB

Comparing AquaBounty Technologies Inc and PharmaCyte Biotech Inc

AQBAquaBounty Technologies Inc

PMCBPharmaCyte Biotech Inc

AQBAquaBounty Technologies Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

10.5%

52W performance

-47.5%

FCF yield

-132.7%

PMCBPharmaCyte Biotech Inc

Market cap

$4M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-45.2%

52W performance

-60.4%

FCF yield

-90.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AQB

PMCB

Detailed metrics comparison

AQB

AquaBounty Technologies Inc

PMCB

PharmaCyte Biotech Inc

Market Cap

AQB$5M

PMCB$4M

Enterprise Value

AQB$4M

PMCB$-13M

Price

AQB$1.05

PMCB$0.40

P/E Ratio

AQBN/A

PMCBN/A

P/S Ratio

AQB3.78x

PMCB107.65x

EV/Sales

AQB2.28x

PMCB-336.93x

EV/EBITDA

AQB0.00x

PMCB0.00x

P/B Ratio

AQB1.69x

PMCB0.14x

P/FCF Ratio

AQBN/A

PMCBN/A

EV/FCF

AQB-0.49x

PMCB3.40x

PEG Ratio

AQBN/A

PMCBN/A

Forward P/E (NTM)

AQBN/A

PMCBN/A

Forward P/S (NTM)

AQBN/A

PMCBN/A

Revenue (TTM)

AQB$0

PMCB$0

Revenue Growth (YoY)

AQB-100.0%

PMCBN/A

Forward Rev Growth

AQB0.0%

PMCB0.0%

Gross Margin (TTM)

AQB0.0%

PMCB81.7%

Operating Margin (TTM)

AQB0.0%

PMCB0.0%

EBITDA Margin (TTM)

AQB0.0%

PMCB0.0%

Net Margin (TTM)

AQB0.0%

PMCB0.0%

FCF Margin (TTM)

AQBN/A

PMCBN/A

Net Income (TTM)

AQB$-18M

PMCB$-21M

FCF (TTM)

AQB$-7M

PMCB$-4M

EPS (TTM)

AQB-$3.56

PMCB-$1.92

ROE (TTM)

AQB-4002.0%

PMCB-4588.0%

ROA (TTM)

AQB-12997.0%

PMCB-3307.0%

ROIC (TTM)

AQB-2623.0%

PMCB-4588.0%

Cash

AQB$2M

PMCB$18M

Debt

AQB$0

PMCB$0

Net Cash/Debt

AQB$2M

PMCB$18M

Current Ratio (TTM)

AQB4.26x

PMCB40.30x

Quick Ratio (TTM)

AQB4.22x

PMCB40.25x

Debt/Equity (TTM)

AQB0.21x

PMCB0.00x

Debt/Assets (TTM)

AQB0.0%

PMCB0.0%

Interest Coverage (TTM)

AQBN/A

PMCBN/A

Net Debt/EBITDA (TTM)

AQB0.00x

PMCB0.00x

Beta

AQB1.45

PMCB0.74

52W Performance

AQB-47.5%

PMCB-60.4%

YTD Performance

AQB10.5%

PMCB-45.2%

% from 52W High

AQB-48.5%

PMCB-73.2%

% from 52W Low

AQB35.6%

PMCB21.1%

Asset Turnover (TTM)

AQB0.01x

PMCB0.02x

FCF Yield (TTM)

AQB-132.7%

PMCB-90.7%

Earnings Yield (TTM)

AQB-339.3%

PMCB-475.0%

Dividend Yield (TTM)

AQBN/A

PMCBN/A

Rule of 40

AQB-100.0

PMCB0.0

EV/GP/RG

AQBN/A

PMCBN/A

Ticker research

View AQB research View PMCB research

Metric	AQB AquaBounty Technologies Inc	PMCB PharmaCyte Biotech Inc
Market & Valuation
Market Cap	$5M	$4M
Enterprise Value	$4M	$-13M
Price	$1.05	$0.40
P/E Ratio	N/A	N/A
P/S Ratio	3.78x	107.65x
EV/Sales	2.28x	-336.93x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.69x	0.14x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.49x	3.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-21M
FCF (TTM)	$-7M	$-4M
EPS (TTM)	-$3.56	-$1.92
ROE (TTM)	-4002.0%	-4588.0%
ROA (TTM)	-12997.0%	-3307.0%
ROIC (TTM)	-2623.0%	-4588.0%
Financial Health
Cash	$2M	$18M
Debt	$0	$0
Net Cash/Debt	$2M	$18M
Current Ratio (TTM)	4.26x	40.30x
Quick Ratio (TTM)	4.22x	40.25x
Debt/Equity (TTM)	0.21x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.74
52W Performance	-47.5%	-60.4%
YTD Performance	10.5%	-45.2%
% from 52W High	-48.5%	-73.2%
% from 52W Low	35.6%	21.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.02x
FCF Yield (TTM)	-132.7%	-90.7%
Earnings Yield (TTM)	-339.3%	-475.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AQB research	View PMCB research

Valuation

P/S Ratio

AQB

3.78x

PMCB

107.65x

EV/FCF

AQB

-0.49x

PMCB

3.40x

Growth & revenue

Revenue Growth TTM

AQB

-100.0%

Forward Revenue Growth

AQB

0.0%

PMCB

0.0%

Profitability & performance

Gross Margin

PMCB

81.7%

AQB

0.0%

ROE

AQB

-4002.0%

PMCB

-4588.0%

FCF Yield %

PMCB

-90.7%

AQB

-132.7%

52-Week Performance

AQB

-47.5%

PMCB

-60.4%

Detailed metrics comparison

AQB

AquaBounty Technologies Inc

PMCB

PharmaCyte Biotech Inc

Market Cap

AQB$5M

PMCB$4M

Enterprise Value

AQB$4M

PMCB$-13M

Price

AQB$1.05

PMCB$0.40

P/E Ratio

AQBN/A

PMCBN/A

P/S Ratio

AQB3.78x

PMCB107.65x

EV/Sales

AQB2.28x

PMCB-336.93x

EV/EBITDA

AQB0.00x

PMCB0.00x

P/B Ratio

AQB1.69x

PMCB0.14x

P/FCF Ratio

AQBN/A

PMCBN/A

EV/FCF

AQB-0.49x

PMCB3.40x

PEG Ratio

AQBN/A

PMCBN/A

Forward P/E (NTM)

AQBN/A

PMCBN/A

Forward P/S (NTM)

AQBN/A

PMCBN/A

Revenue (TTM)

AQB$0

PMCB$0

Revenue Growth (YoY)

AQB-100.0%

PMCBN/A

Forward Rev Growth

AQB0.0%

PMCB0.0%

Gross Margin (TTM)

AQB0.0%

PMCB81.7%

Operating Margin (TTM)

AQB0.0%

PMCB0.0%

EBITDA Margin (TTM)

AQB0.0%

PMCB0.0%

Net Margin (TTM)

AQB0.0%

PMCB0.0%

FCF Margin (TTM)

AQBN/A

PMCBN/A

Net Income (TTM)

AQB$-18M

PMCB$-21M

FCF (TTM)

AQB$-7M

PMCB$-4M

EPS (TTM)

AQB-$3.56

PMCB-$1.92

ROE (TTM)

AQB-4002.0%

PMCB-4588.0%

ROA (TTM)

AQB-12997.0%

PMCB-3307.0%

ROIC (TTM)

AQB-2623.0%

PMCB-4588.0%

Cash

AQB$2M

PMCB$18M

Debt

AQB$0

PMCB$0

Net Cash/Debt

AQB$2M

PMCB$18M

Current Ratio (TTM)

AQB4.26x

PMCB40.30x

Quick Ratio (TTM)

AQB4.22x

PMCB40.25x

Debt/Equity (TTM)

AQB0.21x

PMCB0.00x

Debt/Assets (TTM)

AQB0.0%

PMCB0.0%

Interest Coverage (TTM)

AQBN/A

PMCBN/A

Net Debt/EBITDA (TTM)

AQB0.00x

PMCB0.00x

Beta

AQB1.45

PMCB0.74

52W Performance

AQB-47.5%

PMCB-60.4%

YTD Performance

AQB10.5%

PMCB-45.2%

% from 52W High

AQB-48.5%

PMCB-73.2%

% from 52W Low

AQB35.6%

PMCB21.1%

Asset Turnover (TTM)

AQB0.01x

PMCB0.02x

FCF Yield (TTM)

AQB-132.7%

PMCB-90.7%

Earnings Yield (TTM)

AQB-339.3%

PMCB-475.0%

Dividend Yield (TTM)

AQBN/A

PMCBN/A

Rule of 40

AQB-100.0

PMCB0.0

EV/GP/RG

AQBN/A

PMCBN/A

Ticker research

View AQB research View PMCB research

Metric	AQB AquaBounty Technologies Inc	PMCB PharmaCyte Biotech Inc
Market & Valuation
Market Cap	$5M	$4M
Enterprise Value	$4M	$-13M
Price	$1.05	$0.40
P/E Ratio	N/A	N/A
P/S Ratio	3.78x	107.65x
EV/Sales	2.28x	-336.93x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.69x	0.14x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.49x	3.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-21M
FCF (TTM)	$-7M	$-4M
EPS (TTM)	-$3.56	-$1.92
ROE (TTM)	-4002.0%	-4588.0%
ROA (TTM)	-12997.0%	-3307.0%
ROIC (TTM)	-2623.0%	-4588.0%
Financial Health
Cash	$2M	$18M
Debt	$0	$0
Net Cash/Debt	$2M	$18M
Current Ratio (TTM)	4.26x	40.30x
Quick Ratio (TTM)	4.22x	40.25x
Debt/Equity (TTM)	0.21x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.74
52W Performance	-47.5%	-60.4%
YTD Performance	10.5%	-45.2%
% from 52W High	-48.5%	-73.2%
% from 52W Low	35.6%	21.1%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.02x
FCF Yield (TTM)	-132.7%	-90.7%
Earnings Yield (TTM)	-339.3%	-475.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AQB research	View PMCB research